title: End of rituximab maintenance for low-tumor burden follicular lymphoma.
authors.affiliation: James P. Wilmot Cancer Institute, University of Rochester, Rochester, NY jonathan_friedberg@urmc.rochester.edu.
authors.forename: Jonathan W
authors.initials: JW
authors.lastname: Friedberg
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy*; D008297:Male; D000069283:Rituximab; D047368:Tumor Burden / Q000187:drug effects*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab